Cornerstone Capital Management Holdings’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$184K Sell
6,627
-17,107
-72% -$522K ﹤0.01% 1121
2017
Q3
$735K Sell
23,734
-13,800
-37% -$375K 0.01% 987
2017
Q2
$1.05M Sell
37,534
-8,300
-18% -$200K 0.01% 895
2017
Q1
$1.1M Sell
45,834
-6,566
-13% -$161K 0.01% 905
2016
Q4
$1.33M Buy
52,400
+13,700
+35% +$360K 0.01% 882
2016
Q3
$1.16M Buy
+38,700
New +$1.06M 0.01% 911

Other funds holding SRDX

Cornerstone Capital Management Holdings's SRDX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Surmodics (SRDX) stake by 72% in Q4 2017, selling an estimated $522K and leaving 6,627 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Cornerstone Capital Management Holdings first reported a position in SRDX in Q3 2016 and has held it in 6 quarters since. The position peaked at $1.33M in Q4 2016. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 6,627 shares of Surmodics worth $184K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 17,107 Surmodics shares in Q4 2017, an estimated $522K.
  • Surmodics made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1121 holding.
  • Cornerstone Capital Management Holdings first reported a position in Surmodics in Q3 2016 and has held it in 6 quarters since.
  • Cornerstone Capital Management Holdings's Surmodics position peaked at $1.33M in Q4 2016.
  • 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.